Clinical Trials Logo

Gestational Diabetes clinical trials

View clinical trials related to Gestational Diabetes.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05632055 Active, not recruiting - Clinical trials for Gestational Diabetes

miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

Start date: August 26, 2000
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups. Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.

NCT ID: NCT05543265 Active, not recruiting - Obesity Clinical Trials

Bridging the Gap From Postpartum to Primary Care

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

Chronic health conditions affect most older adults. Preventative medicine and risk management strategies, especially when applied earlier in life, are essential to altering the trajectory of a disease and ultimately improving health outcomes. Primary care providers (PCP) often provide most of these services, though younger adults are the least likely to receive primary care. This project leverages a period of high engagement and health activation during an individual's life (pregnancy) to nudge her toward use of primary care after the pregnancy episode. This randomized controlled trial will test the hypothesis that a behavioral science-informed intervention, incorporating defaults and salience, can increase the rates of PCP follow-up within 4 months following a delivery for individual with hypertension, diabetes, obesity. If successful, this intervention could serve as a scalable solution to increase primary care use and preventative health services in a population that currently has low rates of engagement and utilization of these services.

NCT ID: NCT05430204 Active, not recruiting - Clinical trials for Gestational Diabetes

Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care

NCT ID: NCT05344066 Active, not recruiting - Diabetes Clinical Trials

Manchester Intermittent Diet in Gestational Diabetes Acceptability Study

MIDDAS-GDM
Start date: November 24, 2022
Phase: N/A
Study type: Interventional

A two-arm non-blinded randomised feasibility protocol trial designed to assess the feasibility, safety, and acceptability of an intermittent low energy diet (ILED) vs best National Health Service (NHS) care in women with gestational diabetes and obesity in Greater Manchester.

NCT ID: NCT05096078 Active, not recruiting - Clinical trials for Gestational Diabetes

The Effect of Circuit Exercise Program in Gestational Diabetes

Start date: October 16, 2020
Phase: N/A
Study type: Interventional

Gestational diabetes (GDM) is defined as 'pregnancy-onset or first noticed glucose intolerance'. The aim of this study is to investigate the effect of circuit exercise program applied in addition to diet therapy on cognitive function, functional exercise capacity, mobility, depression and quality of life in women with gestational diabetes. 60 female participants between the ages of 18-35 who meet the inclusion criteria will be included in the study. Participants will be randomly divided into 2 groups as diet group (n=30) and exercise group (n=30). All participants will receive GDM-specific dietary therapy for 6 weeks. In addition to diet therapy, individuals in the exercise group will be given a circuit exercise program for 6 weeks. Participants will be evaluated for blood values, cognitive status and functionality at the baseline and 6 weeks later.

NCT ID: NCT05039307 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Prevention of Type 2 Diabetes and Gestational Diabetes Among Women in Kisantu, Democratic Republic of Congo

KIS-Antwerp
Start date: October 4, 2021
Phase: N/A
Study type: Interventional

This study aims to develop and implement a long-term program focused on the prevention of type 2 diabetes Mellitus (T2DM) and gestational diabetes mellitus (GDM) in women of reproductive age through lifestyle modification. This is a cluster-randomized trial whereby 6 health centers across Kisantu, Democratic Republic of Congo (DRC) will be randomized to an intervention group (3 health centers) or a comparison group (3 health centers). The intervention group will be provided with a preventive program based on educational + motivational strategies when the comparison group will be limited to an educational strategy only. This study will last 24 months and is limited to women of reproductive age (18-49 years), pregnant and non-pregnant. Evaluation of this research will use mixed longitudinal analyses for healthy lifestyle adherence, anthropometric and clinical indicators, diet quality, and physical activity. Expected results of this study for women of reproductive age include the prevention of T2DM and GDM through the acquisition of healthy lifestyle behavior, reaching and maintaining an optimal weight, blood pressure and glycemia, and adhere to the weight gain recommendations during pregnancy. Other expected achievements encompass improvements in the usability of data capturing systems, expand knowledge among health care providers on effective strategies for T2DM and GDM prevention and improve the technique and precision of measurements concerning health visits among health care providers, among others.

NCT ID: NCT04714762 Active, not recruiting - Clinical trials for Gestational Diabetes

eHealth in Treatment of Gestational Diabetes (eMOMGDM)

eMOMGDM
Start date: March 10, 2021
Phase: N/A
Study type: Interventional

The overall aim of the eMOM GDM-project is to develop and evaluate a novel system to clinical decision making and patient behavior change in treatment of GDM, combining diet, physical activity, sleep, heart rate (e.g. stress), and glucose monitoring within a single system (the eMOM GDM application), and linking the developed application tool for the normal health care system in a new way. In this second phase of the project, the effect of eMOM GDM application on maternal and neonatal outcomes will be evaluated in a randomized controlled study design. The follow-up study continues until 3 months postpartum.

NCT ID: NCT04585581 Active, not recruiting - Clinical trials for Gestational Diabetes

Preconception Lifestyle Interventions to Improve Future Metabolic Health (Before the Beginning)

Start date: November 6, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate whether the combination of high intensity exercise and time restricted eating before and during pregnancy can reduce the risk of hyperglycaemia during pregnancy.

NCT ID: NCT04493177 Active, not recruiting - Clinical trials for Overweight and Obesity

Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes

Start date: August 25, 2020
Phase: N/A
Study type: Interventional

In order to evaluate the effect of an educational intervention on mothers with gestational diabetes and their offspring in the first 18 months of life, The intervention will be applied to mothers with gestational diabetes, and a group of mothers without diabetes, against a control group with the normal post-partum treatment. Effects on overweight and obesity will be evaluated in both mothers and offspring.

NCT ID: NCT04324229 Active, not recruiting - Clinical trials for Gestational Diabetes

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes

Liragest
Start date: February 7, 2020
Phase: N/A
Study type: Interventional

Obese women with history of gestational diabetes are in great danger to develop type 2 diabetes (T2D) within 5-10 years after delivery. Aim of the study is to investigate if 12 months' liraglutide treatment could decrease the risk of T2D in obese women who have had gestational diabetes. The women are randomized either to liraglutide (Victoza ® 1.8 mg) or placebo group, once daily. Same laboratory tests are taken and instructions given at baseline 6 month and one year. After one year visits once a year until 5 years with same laboratory tests and measurements are taken.